切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2020, Vol. 13 ›› Issue (04) : 466 -469. doi: 10.3877/cma.j.issn.1674-6902.2020.04.007

论著

诱导痰细胞分类在嗜酸细胞性支气管炎诊断和治疗中的应用
王斌1, 胡明冬2, 徐静1, 张椿3,(), 陈华萍1,(), 王关嵩1, 徐智1, 李琦1   
  1. 1. 400037 重庆,陆军(第三)军医大学第二附属医院全军呼吸内科研究所
    2. 400037 重庆,陆军(第三)军医大学第二附属医院全军呼吸内科研究所;400037 重庆,陆军(第三)军医大学第二附属医院老年与特勤医学科
    3. 400037 重庆,陆军(第三)军医大学第二附属医院医务处
  • 收稿日期:2020-04-17 出版日期:2020-08-25
  • 通信作者: 张椿, 陈华萍
  • 基金资助:
    国家重点研发计划(2017YFC0112702); 陆军军事医学创新工程(18CXZ002); 陆军军医大学第二附属医院临床科研重点项目(2016YLC06)

Effect of induced sputum on diagnosis and treatment of eosinophilic bronchitis

Bin Wang1, Mingdong Hu2, Jing Xu1, Chun Zhang3,(), Huaping Chen1,(), Guansong Wang1, Zhi Xu1, Qi Li1   

  1. 1. Institute of Respiratory Diseases, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
    2. Institute of Respiratory Diseases, Xinqiao Hospital, Army Medical University, Chongqing 400037, China; Department of Gerontology and Secret Service Medicine, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
    3. Medical Department, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
  • Received:2020-04-17 Published:2020-08-25
  • Corresponding author: Chun Zhang, Huaping Chen
引用本文:

王斌, 胡明冬, 徐静, 张椿, 陈华萍, 王关嵩, 徐智, 李琦. 诱导痰细胞分类在嗜酸细胞性支气管炎诊断和治疗中的应用[J]. 中华肺部疾病杂志(电子版), 2020, 13(04): 466-469.

Bin Wang, Mingdong Hu, Jing Xu, Chun Zhang, Huaping Chen, Guansong Wang, Zhi Xu, Qi Li. Effect of induced sputum on diagnosis and treatment of eosinophilic bronchitis[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2020, 13(04): 466-469.

目的

探索诱导痰细胞分类在嗜酸细胞性支气管炎(EB)诊断和治疗中的作用。

方法

回顾性分析我院门诊239例慢性咳嗽患者,依据慢性咳嗽中诊断标准,分为非EB组和EB组,分析两组诱导痰中细胞分类情况;同时给予EB患者进行8周治疗,观察经治疗后诱导痰中各细胞分类的改变情况。

结果

239例慢性咳嗽患者中,非EB患者216例,占90.7%,EB患者23例,占9.3%,两组中共有121例(50.6%)患者诱导痰中嗜酸细胞百分比升高;非EB患者组细胞总计数为(4.83±2.61)×106个/g、嗜酸细胞比例为(4.56±10.07)%、中性粒细胞比例为(50.32±26.12)%、淋巴细胞比例为(5.14±7.27)%、单核巨噬细胞比例为(40.30±16.70)%,EB患者组痰中细胞总计数为(5.46±3.07)×106个/g、嗜酸细胞比例为(13.85±1 2.23)、中性粒细胞比例为(46.16±16.89)、淋巴细胞比例为(4.83±2.98)、单核巨噬细胞比例为(35.91±16.35),两组间EB组嗜酸细胞比例有显著的增多(P<0.05),在性别、年龄以及其余细胞成分差异无统计学意义(P>0.05);EB患者组经治疗后,痰中细胞总计数为(4.07±3.89)×106个/g、嗜酸细胞比例为(2.52±3.80)%、中性粒细胞比例为(54.18±17.97)%、淋巴细胞比例为(5.59±4.33)%、单核巨噬细胞比例为(38.32±17.23)%,嗜酸细胞较治疗前有显著减少(P<0.05),其余细胞改变无显著差异(P>0.05)。

结论

诱导痰细胞分类检查是诊断EB的重要方法,在其诊断和治疗过程中有着重要的指导作用,可作为EB治疗过程的监测指标。

Objective

To explore the effect of induced sputum on the diagnosis and treatment of eosinophilic bronchitis (EB).

Methods

A total of 239 outpatients with chronic cough in our hospital were divided into an EB group and a non-EB group according to the diagnosis standard of EB. The cells in the induced sputum were analyzed for all the patients. Then the patients in the EB group were treated for 8 weeks, and the changes of the induced sputum were detected after treatment.

Results

Among the 239 patients with chronic cough, 216 (90.7%) were non-EB patients and 23 (9.3%) were EB patients. The percentage of eosinophils increased in the induced sputum of 121 (50.6%) patients in the two groups. The total cell count of non-EB patients was (4.83±2.61)×106 cells/g, the proportion of eosinophils accounted for (4.56±10.07)%, and the proportion of neutrophils accounted for (50.32±26.12)%. The percentages of lymphocytes and monocyte-macrophages in the sputum accounted for (5.14±7.27)% and (40.30±16.70)%, respectively. In the induced sputum of the EB group, the total number of cells was (5.46±3.07)×106 cells/g, the proportion of eosinophils accounted for (13.85±12.23)%, the proportion of neutrophils accounted for (46.16±16.89)%, the proportion of lymphocytes accounted for (4.83±2.98)%, and the monocyte-macrophages accounted for (35.91±16.35)%. The proportion of eosinophils was higher significantly in the EB group than the non-EB group (P<0.05). However, no significant difference was found in the sex, age or other cell components (P>0.05). After treatment in the EB group, the total number of cells was (4.70±3.89)×106 cells/g, and the proportion of eosinophils accounted for (2.52±3.80)%, neutrophils for (54.18±17.97)%, lymphocytes for (5.59±4.33)%, and monocyte-macrophages for (38.32±17.23)% in the induced sputum. The proportion of eosinophils after treatment was significantly reduced compared with that before treatment (P<0.05). Similarly, there was no significant difference in other cell changes (P>0.05).

Conclusion

Analyzing the induced sputum was an important method for the diagnosis of EB, which plays an important role in the diagnosis and treatment of EB, and can also be used as a detection index in the treatment of EB.

表1 非EB组与EB患者诱导痰细胞分类比较
图1 EB患者治疗前后诱导痰细胞变化;注:EOS:嗜酸细胞;NEU:中性粒细胞;MAC:单核巨噬细胞
表2 EB患者治疗前后诱导痰中细胞分类变化
1
Irwin RS, French CL, Chang AB, et al. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report[J]. Chest, 2015, 3(1): 196-209.
2
中华医学会呼吸病学分会哮喘学组. 咳嗽的诊断与治疗指南(2015)[J]. 中华结核和呼吸杂志,2016, 39(5): 323-354.
3
Lai K, Chen R, Lin J, et al. A prospective, multicenter survey on causes of chronic coughin China[J]. Chest, 2013, 143(3): 613-620.
4
Gibson PG, Dolovich J, Denburg J, et al. Chronic cough: eosinophilic bronchitis without asthma[J]. Lancet, 1989, 333(8651): 1346-1348.
5
中华医学会,咳嗽基层诊疗指南(实践版-2018)[J]. 中华全科医师杂志,2019, 18(3): 220-227.
6
中国医师协会呼吸医师分会. 无创气道炎症评估支气管哮喘的临床应用中国专家共识[J]. 中华结核和呼吸杂志,2015, 38(5): 329-341.
7
陈华萍,马千里,张 巧,等. 重庆地区健康成人诱导痰细胞计数及正常参考值的初步建立[J]. 第三军医大学学报,2011, 33(24): 2611-2613.
8
赖克方. 慢性咳嗽[M]. 第1版,北京:人民卫生出版社,2008: 150-178.
9
DI Stefano F, DI Giampaolo L, Verna N. Occupational eosinophilic bronchitis in a foundry worker exposed to isocyanate and a baker exposed to flour[J]. Thorax, 2007, 62(4): 386-370.
10
Guo CL, Sun XM, Wang XW, et al. Serum Eosinophil Cationic Protein Is a Useful Marker for Assessing the Efficacy of Inhaled Corticosteroid Therapy in Children with Bronchial Asthma[J]. Tohoku J Exp Med, 2017, 242(4): 263-271.
11
罗 炜,赖克方,陈如冲,等. 嗜酸粒细胞性支气管炎气道炎症病理特征的探讨[J]. 中国病理生理杂志,2006, 22(5):943-947.
12
赖克方,钟南山. 嗜酸粒细胞性支气管炎及其与支气管哮喘的关系[J]. 内科理论与实践,2011, 6(2): 88-91.
13
Brightling CE, Pavord ID. Eosinophilic bronchitis-what is it andwhy is it important[J]. Clin Exp Allergy, 2000, 30(1): 4.
14
罗 炜,赖克方,陈如冲,等. 痰嗜酸细胞和ECP在嗜酸细胞性支气管炎诊断中的作用[J]. 广东医学,2006, 27(3):345-346.
15
Pijnenburg MW. The Role of FeNO in Predicting Asthma[J]. Front Pediatr, 2019, 7: 41.
16
Arnold RJ, Massanari M, Lee TA, et al. A Review of the Utility and Cost Effectiveness of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management[J]. Manag Care, 2018, 27(7): 34-41.
17
Shaw DE. FeNO monitoring to adjust treatment in asthma: has it come of age[J]? Thorax, 2018, 73(12): 1095-1096.
18
Wang Z, Pianosi P, Keogh K, et al. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management[J]. Rockville (MD): Agency for Healthcare Research and Quality (US), 2017,.: 17(18)-EHC030-EF.
19
Song WJ, Kim HJ, Shim JS, et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough: A systematic review and meta-analysis[J]. J Allergy Clin Immunol, 2017, 140(3): 701-709.
20
张永明,林江涛,苏 楠,等. 呼出气一氧化氮检测在慢性咳嗽病因诊断中的价值[J]. 中华医学杂志,2011, 91(18): 1254- 1258.
21
陈华萍,唐心蔚,周雪梅,等. FeNO与诱导痰细胞分类检测的相关性[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 223-225.
22
Desai D, Brightling C. Cough due to asthma, cough-variant asthma and non-asthmatic eosinophilic bronchitis[J]. Otolaryngol Clin North Am, 2010, 43(1): 123-130.
23
Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients[J]. Am J Respir Crit Care Med, 2008, 177(1): 27-34.
24
Zhang S, Wang S, Wan Z, et al. Quantitative real-time PCR and Platelia galactomannan assay for the diagnosis of invasive pulmonary aspergillosis: bronchoalveolar lavage fluid performs better than serum in non-neutropaenic patients[J]. Mycopathologia, 2016, 181(9-10): 625-629.
25
He H, Ding L, Sun B, et al. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study[J]. Crit Care, 2012, 16(4): R138.
26
Luo W, Chen QL, Chen RC, et al. Reference value of induced sputum cell counts and its relationship with age in healthy adults in Guangzhou, Southern China[J]. The Clinical Respiratory Journal, 2018, 12(3): 1160.
27
李战炜,唐 伟. 培土生金方联合BiPAP呼吸机对慢性阻塞性肺疾病加重期合并Ⅱ型呼吸衰竭痰细胞分类、血ECP变化的影响[J]. 世界中西医结合杂志,2019, 14(10): 1415-1418.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[3] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[4] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
[5] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[6] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[7] 许丁伟, 马江云, 李新成, 黄洁. Alagille综合征疑诊为先天性胆道闭锁一例并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 681-687.
[8] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[9] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[10] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[11] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[12] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[13] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[14] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要